HOME >> BIOLOGY >> NEWS
Prozac improves learning and memory in fatal brain disease

Howard Florey Institute scientists in Melbourne have found that fluoxetine (commonly marketed as Prozac) not only improves depression in Huntington's disease, but also improves learning and memory.

Dr Anthony Hannan and his team also found that fluoxetine restores the brain's process of neurogenesis - the birth of new neurons - to normal levels, which helps delay the onset of the inherited fatal disease.

People with Huntington's disease have progressive motor problems, cognitive deficits (dementia) and psychiatric symptoms (the most common is depression) that usually start to appear in mid-life. There is no cure and death usually results within 10 to 20 years of symptom onset, or faster in the childhood-onset form of the disease. The disease is caused by a mutation in a single gene and when this defective gene is passed from parent to child, 50 percent of the offspring will inherit the disorder, which can be detected by genetic testing.

Dr Hannan said this discovery was an important step in developing effective treatments to delay the onset of symptoms and the progression of Huntington's disease.

"Now that we've found fluoxetine improves memory problems, or dementia, as well as depression in mice with Huntington's disease, further research can be conducted to see if the drug has the same benefits in humans with the disease," Dr Hannan said.

"We have started discussing arrangements with colleagues to begin human trials to see if fluoxetine, and related drugs, are also effective treatments in people with the disease."

"Fluoxetine's ability to promote the birth of new neurons in the normal and Huntington's brain provides new insight into the biological basis of depression, as well as other brain disorders involving dementia. It also suggests new applications for these antidepressant drugs," he said.

During the study, mice with the Huntington's gene and control mice were treated daily with either fluoxetine
'"/>

Contact: Merrin Rafferty
61-383-441-658
Research Australia
6-Oct-2005


Page: 1 2

Related biology news :

1. Prozac exposure found to disrupt mussel reproduction
2. Ingredient in Prozac increases risk of extinction for freshwater mussels
3. Prozacs target revealed
4. New test improves detection of liver cancer
5. Jefferson scientists patent dramatically improves
6. Co-operation between GSF and clinic improves outlook for sarcoma patients
7. HIV survival improves if patients stay in care
8. Preterm infants with RDS -- surfactant replacement therapies improves neonatal survival
9. New knowledge improves rice quality
10. Statin treatment improves spatial memory in mouse models of Alzheimers
11. Mutation improves memory, may lead to memory-enhancing pill

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/6/2019)... ... November 06, 2019 , ... In October, Massachusetts stem cell ... patients about a poorly disclosed deficiency in stem cell treatments. Throughout stem ... the treating stem cells. This problem affects all patients receiving stem cell ...
(Date:11/2/2019)... , ... October 31, 2019 , ... In this podcast, ... a successful career in research and consulting. , The Beyond the Lab Podcast is ... feature interviews from alumni who have jobs in the biomedical field — and in ...
(Date:10/30/2019)... BALTIMORE, Md. (PRWEB) , ... October 30, 2019 ... ... at the 12th Annual CBRNe Convergence in Nashville, TN from Tuesday, November 5, ... and military responses to CBRNe (chemical, biological, radiological, nuclear) and IED (explosive) threats. ...
Breaking Biology News(10 mins):
(Date:11/20/2019)... ... 2019 , ... Defense and aerospace market intelligence firm Forecast ... from 2019-2028. The value of this production is $728 million in 2019 dollars. ... million. , Reference to 2017 is important, as that was a pivotal ...
(Date:11/19/2019)... ... 19, 2019 , ... Supercomputing Conference – Cirrascale Cloud ... Autonomous Vehicle , Medical Imaging, and Natural Language Processing (NLP) workflows, today ... Poplar® software stack as part of its bare-metal cloud service offerings. In addition ...
(Date:11/12/2019)... ... November 12, 2019 , ... REPROCELL ... have been selected by Lantern Pharma to provided preclinical screening and drug sensitivity ... of data points using panels of unique and genetically edited cell lines from ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... announced that Immatics Biotechnologies , a clinical-stage biopharmaceutical company developing T-cell ... their R&D operations related to the discovery and development of high-affinity and ...
Breaking Biology Technology:
Cached News: